FOXO3 and malignant colon neoplasm: We found that FOXO3 was a significantly protective factor in disease-specific survival (DSS), overall survival (OS), and progression-free survival (PFS) for kidney clear cell carcinoma (KIRC), uveal melanoma (UVM), and colon cancer (COAD) (Figure 2A).